J
Jörn D. Beck
Researcher at University of Erlangen-Nuremberg
Publications - 47
Citations - 2019
Jörn D. Beck is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Breakpoint & Gene. The author has an hindex of 22, co-authored 47 publications receiving 1921 citations. Previous affiliations of Jörn D. Beck include University of Hamburg.
Papers
More filters
Journal ArticleDOI
Malignant peripheral neuroectodermal tumors. A retrospective analysis of 42 patients.
Herbert Jürgens,Gerlinde Etspüler,Ulrich Göbel,Verena Bier,Werner Brandeis,Dieter Harms,Dieter Schmidt,Jörn D. Beck,Helmut Gadner,Jörn Treuner,Kurt Winkler +10 more
TL;DR: In patients with primary chemotherapy after biopsy‐proven diagnosis, the responsiveness of this disease to chemotherapy could be demonstrated, and Combination chemotherapy containing anthracyclines and high doses of alkylating agents appeared superior.
Journal ArticleDOI
CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory.
Thorsten Langer,Peter Martus,Holger Ottensmeier,Holger Hertzberg,Jörn D. Beck,Walburga Meier +5 more
TL;DR: The neuropsychological function is defined and which central nervous system functions are impaired following the German ALL-BFM and COALL protocols for CNS-negative patients are described to support the strategy of avoiding prophylactic CNS irradiation in low risk patients.
Journal ArticleDOI
High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations.
Thomas Rau,Thomas Rau,Birgit Erney,Birgit Erney,Ralf Göres,Ralf Göres,Thomas Eschenhagen,Thomas Eschenhagen,Jörn D. Beck,Jörn D. Beck,Thorsten Langer,Thorsten Langer +11 more
TL;DR: The adenosine triphosphate‐binding cassette (ABC) class transporter ABCC2 (MRP2 [multidrug resistance related protein 2] or cMOAT [canalicular multispecific organic anion transporter]).
Journal ArticleDOI
Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)--experiences from trial ALL-BFM 95.
TL;DR: A group‐wide evaluation was performed to determine incidence, risk factors, and morbidity for ON, due to spontaneous reporting of affected patients with ON.
Journal ArticleDOI
Exon/intron structure of the human ALL‐1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias
TL;DR: A set of genomic fragments was isolated that represent a total of 35 exons encompassing > 95% of the protein‐coding region and the 3′‐non‐translated region of the All‐1 gene and form the basis for a greater understanding of the translocations and other structural alterations of the gene that conserve the open reading frame and thus produce presumably oncogenic variants of the ALL‐1 protein.